180
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Non-Clinical Safety Pharmacology Evaluations of Trazpiroben (TAK-906), a Novel Dopamine D2/D3 Selective Receptor Antagonist for the Management of Gastroparesis

, , &
Pages 43-57 | Published online: 09 Feb 2022